Mumbai, May 7 (IANS) The Indian equity markets traded higher on Thursday in morning trade amid hopes of the US-Iran peace deal.Sensex climbed as much as 0.48 per cent, or 380 points, to hit an intraday high of 78,339.24 in early trade, while Nifty traded at 24,423.35, up 0.37 per cent or 92 points.Meanwhile, from the Nifty pack, Tata Consumer, Power Grid, Hindustan Unilever, TCS, HDFC Bank, Titan, NTPC, and Sun Pharma were among the top losers.Sectoral indices — Nifty Realty, Nifty FMCG, Nifty …
Latest Sun Pharma News & Updates
Boston, May 1 (IANS) India’s emergence as a global pharmaceutical powerhouse is entering a new phase, driven by innovation, vaccine leadership and expanding clinical capabilities, according to Dr Elias Zerhouni, former Director of the US National Institutes of Health (NIH).Zerhouni said the India-US relationship in healthcare and biotechnology has steadily strengthened over the years, moving beyond manufacturing to innovation-led collaboration.“There’s a tremendous amount of exchanges and …
Mumbai, April 27 (IANS) Indian equity benchmarks closed near the day’s high on improved investor sentiment after India-New Zealand FTA finalised in the national capital.The agreement which sealed in the presence of Commerce Minister Piyush Goyal and his New Zealand counterpart Todd McClay removes tariffs on 100 per cent of India’s exports to New Zealand, and either sharply reduces or removes tariffs on 95 per cent of the country’s imports from New Zealand.At the closing bell, the Nifty end…
Mumbai, April 27 (IANS) Indian stock markets traded higher in early deals on Monday, with benchmark indices surging about 0.6 per cent each, driven by positive global cues. Sensex traded at 77,121.97, up 0.59 per cent or 457 points in early trade, while Nifty climbed to 24,047, rising 150 points or 0.62 per cent from the previous close, led by buying in realty, pharma, IT, auto, and banking stocks.However, Axis Bank, Shriram Finance, and Bajaj Finance were among the top laggards.Earlier in the s…
Mumbai, April 24 (IANS) The domestic equity markets saw negative performance in early hours on Friday amid elevated geopolitical tensions and the Q4 earnings season.Sensex was trading at 77,263, down 0.51 per cent or 400 points, while Nifty was down 0.41 per cent, or 100 points, in early trade amid panic selling in IT, financial and pharma stocks. However, support was seen in FMCG and chemical scrips.Cipla, Infosys, Dr Reddy’s Laboratories, Sun Pharma, TCS and ICICI Bank were among the top lag…
New Delhi, April 15 (IANS) Healthcare companies in India are expected to deliver high single-digit revenue growth (year-on-year) in the fourth quarter of FY26 (Q4 FY26), a report showed on Wednesday.However, EBITDA margins will materially be corrected, according to the report by Systematix.“Median growth is estimated at 12 per cent for revenue and 3.6 per cent for EBTIDA, with net earnings likely witnessing a 14 per cent decline, the report mentioned.The primary driver of this on-year decline …
Mumbai, April 10 (IANS) Indian equity benchmarks traded sharply higher on Friday, mirroring gains in global markets despite fresh geopolitical tensions and concerns over the closure of the Strait of Hormuz.Sensex climbed as much as 0.82 per cent or 630 points to hit an intra-day high of 77261 in early trade, while Nifty surged 0.85 per cent or 203 points to trade at 23,978.Earlier, the 30-share Sensex opened at 77,121, up 0.64 per cent or 489 points, while the 50-share index began the session at…
Mumbai, April 3 (IANS) Indian equity markets closed lower for the sixth consecutive week amid escalating geopolitical tensions in West Asia and sharp currency fluctuations, with both headline indices ending in the red during a shortened four-day trading week.Sensex ended at 73,319.55 on Thursday, down 263.67 points or 0.35 per cent, compared to the previous Friday’s close. Nifty 50 settled at 22,713.10, a decline of 106.50 points or 0.46 per cent on a week-on-week basis.In the final session of t…
Mumbai, April 2 (IANS) Indian stock markets opened sharply lower on Thursday, with key equity benchmarks declining more than 1 per cent amid fresh escalation in the West Asia conflict.Sensex opened at 72,262, down 872 points or 1.19 per cent, while the Nifty fell 1.31 per cent or around 300 points to open at 22,383.40. Both the indices fell further as trading progressed in early hours.All sectors opened in the red, with banking, realty, chemicals, auto, metal, and healthcare among the top losers…
New Delhi, March 21 (IANS) Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lower‑cost options for patients managing Type 2 diabetes and obesity.The companies, namely Sun Pharma, Zydus Lifesciences, and Dr. Reddy’s Laboratories, launched their variants a day after Hyderabad-based Natco Pharma launched its generic semaglutide injection in India, priced at Rs 1,290 per month.Sun Pharma launched semaglutide…